Federal regulators have assigned a formal severity rating to the recall of neonatal and infant breathing circuits pulled from hospitals nationwide, placing it in the middle of the FDA's three-tier system rather than the most serious category.
The agency classified the Medline recall of Hudson RCI neonatal and infant heated wire breathing circuits as Class II. That designation applies to devices that may cause temporary or reversible health problems, or, though unlikely, serious health problems. It sits below Class I, the tier reserved for devices that may cause serious injury or death.
The classification does not change what hospitals were already told to do. Affected circuits still must be identified, quarantined, and destroyed once the recall response form is complete. What changes is the risk estimate attached to the event, and that is the piece parents of infants in neonatal intensive care have been waiting on.
A Classification That Narrows the Risk Estimate
The sequence matters for reading this correctly. On August 21, the FDA issued an Early Alert, a communication the agency uses to flag a potentially high-risk device issue while its review is still underway. Readers unfamiliar with the term can see the agency's own description of what an Early Alert means. It is a warning issued before conclusions are reached, not a finding.
The Class II classification, posted on September 1, is the conclusion of that review. In practical terms, regulators looked at the failure mode and the reported outcomes and determined the probability of serious harm is low. Medline had not reported any serious injuries or deaths associated with the issue as of July 31, according to the FDA recall notice.
MedicalDaily previously reported on the initial alert and the item numbering confusion that complicated hospital stock checks. At that stage, the severity rating had not been assigned.
The contrast with a Class I event is instructive. MedicalDaily also covered a separate breathing circuit recall involving Hamilton Medical ventilators that received the most serious classification after four reported serious injuries. Both involve circuits. The tiers are not the same, and the difference is the agency's judgment about likely harm.
Families with an Infant on Ventilator Support
The underlying defect is worth understanding plainly. Medline received reports of sporadic failures at the heated wire connector, sometimes called the pigtail, where the circuit meets the Neptune humidifier. Affected connectors could show discoloration, melting, smoke, a burning odor or other signs of localized thermal damage.
A safety feature limits how far that can escalate. The humidifier continuously monitors the heated wire circuit and automatically cuts power to the heated wires when it detects electrical abnormalities. Respiratory gas keeps flowing to the infant. Only the heating function stops.
The consequences flow from that loss of heating rather than from fire. Gas that is inadequately warmed and humidified can dry and damage the airway lining, which the FDA notes can predispose an infant to bronchospasm, thickened secretions, and airway obstruction. Loss of heated wire function can also increase condensation inside the tubing, described as rainout, which can cause unintended positive end-expiratory pressure, circuit obstruction, or pooled fluid entering the airway. Colder, drier gas raises the risk of cold stress, which increases oxygen consumption and can worsen respiratory distress. The agency recommends increased vigilance in monitoring ventilators, circuits, and humidification systems.
Parents with an infant currently on ventilator support can ask the care team whether the unit uses Hudson RCI heated wire circuits, whether affected lots have been quarantined, and what the humidification monitoring plan looks like. Those are routine questions in a neonatal unit. Parents worried about an infant who was on ventilator support in recent months should raise it directly with the treating clinician rather than trying to match lot numbers themselves.
The Labeling Problem Hospitals Still Face
One complication from the earlier stage has not gone away. Some affected circuits carry item numbers that do not match the numbers listed in Medline's original notice, which was sent to customers on July 13, with follow-up letters on July 27 and August 5.
The reason is a manufacturing transition. Circuits produced before January 2024 carry a Teleflex label and Teleflex item number, in formats such as 780-07 or 880-14KIT. Circuits produced from January 2024 onward carry a Medline label and Medline item number, in formats such as HUD78007 or HUD88014KIT. A facility checking against only one numbering system could miss affected stock sitting on a shelf.
Eighteen product configurations appear on the agency's summary table, and a full list of affected products is published separately. Distributors who resold or transferred the product are instructed to notify their own customers and include those quantities on the response form.
Reporting Channels and Next Steps
The FDA has not announced further action beyond the classification, and no expansion of the recall has been reported. Because Class II is the conclusion of the agency's review rather than an interim step, the most likely future development would be new adverse event reports rather than a reclassification.
Several things remain unconfirmed. The total number of affected circuits in circulation has not been published. Whether any patient experienced a clinical consequence that was never linked to the connector fault is unknown, which is a general limitation of passive reporting systems. The company reported no serious injuries or deaths as of July 31, and that date is the boundary of what is currently known rather than a permanent finding.
Hospitals and clinicians in the United States with questions can contact Medline at 866-359-1704 or by email at [email protected]. Device problems can be reported through the MedWatch adverse event reporting program. MedicalDaily will report any recall expansion, any change in classification, and any reported patient injury.
Key Questions Answered
What changed in this update? The FDA classified the recall as Class II, its middle severity tier, after previously issuing an Early Alert while its review was underway.
What does Class II mean? It applies to devices that may cause temporary or reversible health problems, or, though unlikely, serious health problems. It is less severe than Class I.
Have any infants been hurt? Medline had not reported any serious injuries or deaths associated with this issue as of July 31.
What is the actual defect? The heated wire connector at the humidifier can discolor, melt, smoke or give off a burning odor, and the humidifier then cuts power to the heated wires.
Does gas flow stop if that happens? No. Respiratory gas continues flowing to the infant. Only the wire heating function is disconnected.
Why are hospitals confused about item numbers? Circuits made before January 2024 carry Teleflex numbers, and those made later carry Medline numbers, so one list alone can miss affected stock.
What should parents ask? Whether the unit uses Hudson RCI heated wire circuits, whether affected lots were quarantined, and what the humidification monitoring plan is.
